Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Financing Activities: 2013-2025

Historic Cash from Financing Activities for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $15.1 million.

  • Fortress Biotech's Cash from Financing Activities rose 455.96% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 10.27%. This contributed to the annual value of $70.6 million for FY2024, which is 115.77% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Cash from Financing Activities is $15.1 million, which was up 233.38% from $4.5 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Cash from Financing Activities high stood at $78.7 million for Q1 2021, and its period low was -$30.4 million during Q2 2023.
  • Its 3-year average for Cash from Financing Activities is $15.9 million, with a median of $15.1 million in 2025.
  • Per our database at Business Quant, Fortress Biotech's Cash from Financing Activities slumped by 1,115.75% in 2023 and then surged by 455.96% in 2025.
  • Fortress Biotech's Cash from Financing Activities (Quarterly) stood at $38.9 million in 2021, then slumped by 52.19% to $18.6 million in 2022, then spiked by 134.28% to $43.6 million in 2023, then tumbled by 40.84% to $25.8 million in 2024, then soared by 455.96% to $15.1 million in 2025.
  • Its Cash from Financing Activities stands at $15.1 million for Q3 2025, versus $4.5 million for Q2 2025 and $52.1 million for Q1 2025.